Form D · Hedge Fund
Renaissance Kaleidoscope RF Fund LLC
New York, NY · CIK 0001549430
Offering snapshot reported Jan 13, 2022 · SEC filing
- Reported sold
- $6.03M Indefinite offering
- Investors reported
- 21 Form D · investor count
- Minimum accepted
- $1K Reported outside-investor minimum
- First sale
- May 1, 2012 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$4,590,761 → $6,026,464
- Reported investors20 → 21
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 13, 2022 | Amendment | $6,026,464 | $1,435,703vs Jan 15, 2021 | 21 | SEC filing |
| Jan 15, 2021 | Amendment | $4,590,761 | $2,659,356vs Jan 15, 2020 | 20 | SEC filing |
| Jan 15, 2020 | Amendment | $1,931,405 | $197,618vs Nov 8, 2019 | 18 | SEC filing |
| Nov 8, 2019 | Amendment | $1,733,787 | $0vs Oct 15, 2019 | 18 | SEC filing |
| Oct 15, 2019 | Amendment | $1,733,787 | $592,394vs Oct 16, 2018 | 18 | SEC filing |
| Oct 16, 2018 | Amendment | $1,141,393 | $399,527vs Oct 16, 2017 | 18 | SEC filing |
| Oct 16, 2017 | Amendment | $741,866 | $142,166vs Oct 14, 2016 | 17 | SEC filing |
| Oct 14, 2016 | Amendment | $599,700 | $402,520vs Oct 15, 2015 | 17 | SEC filing |
| Oct 15, 2015 | Initial | $197,180 | No comparison | 17 | SEC filing |
| May 13, 2014 | Amendment | $26,299,358 | $175,620vs May 13, 2013 | 27 | SEC filing |
| May 13, 2013 | Amendment | $26,123,738 | $381,515vs May 15, 2012 | 20 | SEC filing |
| May 15, 2012 | Initial | $25,742,223 | No comparison | 16 | SEC filing |
Offering details
- Securities
- Pooled investment fund
- Exemptions
- 06b, 3C, 3C.1
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-249411
Source: Form D, filed Jan 13, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Dr. Paul Broder | Director |
| Peter P. Brophy | Executive |
| Dr. Peter F. Brown | Director, Executive |
| Mark Heising | Director |
| Edward Hubner | Executive |
| Dr. Henry Laufer | Director |
| Dr. David Lippe | Director, Executive |
| Dr. Robert L. Mercer | Director, Executive |
| Tiffany T. Michel | Executive |
| James S. Rowen | Director, Executive |
| Mark Silber | Director |
| Nathaniel Henry Simons | Director |
| Dr. James H. Simons | Director |
| Anne K. Small | Director, Executive |
| Dr. Alan Stange | Director, Executive |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:New York, NY, 10022